Background:The possibility exists that cocaine use in the absence
of frank clinical presentation of acute cardiac events may be associated with
subclinical injury including the release of myoglobin which is a nonspecific
marker for cardiac and skeletal muscle damage.Objectives: This investigation examined urine specimens for
potential differences between cocaine use and the
expression of myoglobin (a marker associated with cardiovascular damage,
inflammation and oxidative stress).Methods:40 urine specimens were assayed for cocaine metabolites,
creatinine, total protein (BSA) and myoglobin using ELISA and colorimetry. Results:We observed significant differences between male control
and male cocaine positive urines for myoglobin. Interestingly, there was no
statistically significant difference in females between control and cocaine
positive urines. Conclusion:Differences in the urinary
expression of myoglobin may be important in evaluating the gender based effects
of cocaine use and may have potential clinical applications which may be
related to gender differences in signs and symptoms of cocaine toxicity.
Cite this paper
M. Bourgeois and I. Richards, "Expression of Myoglobin in the Urine of Cocaine Users," International Journal of Clinical Medicine, Vol. 4 No. 4, 2013, pp. 217-221. doi: 10.4236/ijcm.2013.44038.
 J. A. Jaffe and P. L. Kimmel, “Chronic Nephropathies of Cocaine and Heroin Abuse: A Critical Review,” Clinical Journal of the American Society of Nephrology, Vol. 1, No. 4, 2006, pp. 655-667. doi:10.2215/CJN.00300106
 S. Aslibekyan, E. B. Levitan and M. A. Mittleman, “Prevalent Cocaine Use and Myocardial Infarction,” American Journal of Cardiology, Vol. 102, No. 8, 2008, pp. 966-969. doi:10.1016/j.amjcard.2008.06.016
 K. D. Meyer and L. Zhang, “Shortand Long-Term Adverse Effects of Cocaine Abuse during Pregnancy on the Heart Development,” Therapeutic Advances in Cardiovascular Disease, Vol. 3, No. 1, 2009, pp. 7-16.
 R. J. Devlin and J. A. Henry, “Clinical Review: Major Consequences of Illicit Drug Consumption,” Critical Care, Vol. 12, No. 1, 2008, p. 202. doi:10.1186/cc6166
 C. S. Restrepo, C. A. Rojas, S. Martinez, R. Riascos, A. Marmol-Velez, J. Carrillo, et al., “Cardiovascular Complications of Cocaine: Imaging Findings,” Emergency Radiology, Vol. 16, No. 1, 2009, pp. 11-19.
 K. B. Keller and L. Lemberg, “The Cocaine-Abused Heart,” American Journal of Critical Care, Vol. 12, No. 6, 2003, pp. 562-566.
 E. Y. Plotnikov, A. A. Chupyrkina, I. B. Pevzner, N. K. Isaev and D. B. Zorov, “Myoglobin Causes Oxidative Stress, Increase of No Production and Dysfunction of Kidney’s Mitochondria,” Biochimica et Biophysica Acta, Vol. 1792, No. 8, 2009, pp. 796-803.
 R. A. Kloner and S. H. Rezkalla, “Cocaine and the Heart,” The New England Journal of Medicine, Vol. 348, No. 6, 2003, pp. 487-488. doi:10.1056/NEJMp020174
 SAMSHA, “Results from the 2008 National Survey on Drug Use and Health: National Findings,” Office of Applied Studies, Rockville, 2009
 B. Ostadal, I. Netuka, J. Maly, J. Besik and I. Ostadalova, “Gender Differences in Cardiac Ischemic Injury and Protection—Experimental Aspects,” Experimental Biology and Medicine, Vol. 234, No. 9, 2009, pp. 1011-1019.
 A. A. Quyyumi, “Women and Ischemic Heart Disease: Pathophysiologic Implications from the Women’s Ischemia Syndrome Evaluation (WISE) Study and Future Research Steps,” Journal of the American College of Cardiology, Vol. 47, No. 3S, 2006, pp. S66-S71.
 R. A. Kloner, S. Hale, K. Alker and S. Rezkalla, “The Effects of Acute and Chronic Cocaine Use on the Heart,” Circulation, Vol. 85, No. 2, 1992, pp. 407-419.
 H. F. Poon, L. Abdullah, M. A. Mullan, M. J. Mullan and F. C. Crawford, “Cocaine-Induced Oxidative Stress Precedes Cell Death in Human Neuronal Progenitor Cells,” Neurochemistry International, Vol. 50, No. 1, 2007, pp. 69-73. doi:10.1016/j.neuint.2006.06.012
 I. S. Richards, “Health Effects of Illicit Cocaine Use,” Pulmonary and Critical Care Update American College of Chest Physicians, Vol. 7, No. 2, 1991, pp. 1-7.
 J. R. Richards, “Rhabdomyolysis and Drugs of Abuse,” Journal of Emergency Medicine, Vol. 19, No. 1, 2000, pp. 51-56. doi:10.1016/S0736-4679(00)00180-3
 T. Pisitkun, R. Johnstone and M. A. Knepper, “Discovery of Urinary Biomarkers,” Molecular & Cellular Proteomics, Vol. 5, No. 10, 2006, pp. 1760-1771.
 D. Seger, “Cocaine, Metamfetamine, and MDMA Abuse: The Role and Clinical Importance of Neuroadaptation,” Clinical Toxicology (Philadelphia), Vol. 48, No. 7, 2010, pp. 695-708. doi:10.3109/15563650.2010.516263
 G. Silvestrelli, F. Corea, S. Micheli and A. Lanari, “Clinical Pharmacology and Vascular Risk,” Open Neurology Journal, Vol. 4, 2010, pp. 64-72.
 S. B. Karch, “Karch’s Pathology of Drug Abuse,” 4th Edition, CRC/Taylor & Francis, Boca Raton, 2009.
 A. I. Qureshi, M. F. Suri, L. R. Guterman and L. N. Hopkins, “Cocaine Use and the Likelihood of Nonfatal Myocardial Infarction and Stroke: Data from the Third National Health and Nutrition Examination Survey,” Circulation, Vol. 103, No. 4, 2001, pp. 502-506.
 P. M. Johnson and P. J. Kenny, “Dopamine D2 Receptors in Addiction-Like Reward Dysfunction and Compulsive Eating in Obese Rats,” Nature Neuroscience, Vol. 13, No. 5, 2010, pp. 635-641. doi:10.1038/nn.2519
 C. W. Callaway and R. F. Clark, “Hyperthermia in Psychostimulant Overdose,” Annals of Emergency Medicine, Vol. 24, No. 1, 1994, pp. 68-76.
 D. Roth, F. J. Alarcon, J. A. Fernandez, R. A. Preston and J. J. Bourgoignie, “Acute Rhabdomyolysis Associated with Cocaine Intoxication,” The New England Journal of Medicine, Vol. 319, No. 11, 1988, pp. 673-677.
 R. J. de Winter, R. W. Koster, A. Sturk and G. T. Sanders, “Value of Myoglobin, Troponin T, and CK-MB Mass in Ruling Out an Acute Myocardial Infarction in the Emergency Room,” Circulation, Vol. 92, No. 12, 1995, pp. 3401-3407. doi:10.1161/01.CIR.92.12.3401
 M. P. Hudson, R. H. Christenson, L. K. Newby, A. L. Kaplan and E. M. Ohman, “Cardiac Markers: Point of Care Testing,” Clinica Chimica Acta, Vol. 284, No. 2, 1999, pp. 223-237. doi:10.1016/S0009-8981(99)00083-2